Brief: PCI Biotech initiates preclinical research collaboration in siRNA therapeutics

PCI Biotech Holding ASA

07/04/2015 07:01

April 7 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :  
    * Says is initiating a pre-clinical research collaboration 
with RXi Pharmaceuticals, an American biotechnology company 
focused on discovering and developing innovative therapeutics, 
that address high-unmet medical needs primarily in the area of 
dermatology and ophthalmology 
    * Says the partnership is governed by a pre-clinical 
research collaboration agreement 
    * Initially, the purpose of the pre-clinical research 
collaboration is to utilize the companies' complementary 
scientific platforms to explore potential synergies 
    * Both companies will retain exclusive ownership rights to 
existing registered intellectual property 
 
Source text for Eikon:  ID:nHUG5xP4BJ  
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48586983920;))